Wuhan Hiteck Biological Pharma Co (SZSE:300683) Other Long Term Assets : ¥363.9 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Wuhan Hiteck Biological Pharma Co Other Long Term Assets?

Wuhan Hiteck Biological Pharma Co's other long-term assets for the quarter that ended in Mar. 2025 was ¥363.9 Mil.

Wuhan Hiteck Biological Pharma Co's quarterly other long-term assets declined from Sep. 2024 (¥365.0 Mil) to Dec. 2024 (¥357.8 Mil) but then increased from Dec. 2024 (¥357.8 Mil) to Mar. 2025 (¥363.9 Mil).

Wuhan Hiteck Biological Pharma Co's annual other long-term assets declined from Dec. 2022 (¥215.0 Mil) to Dec. 2023 (¥186.2 Mil) but then increased from Dec. 2023 (¥186.2 Mil) to Dec. 2024 (¥357.8 Mil).

Wuhan Hiteck Biological Pharma Co Other Long Term Assets Historical Data

The historical data trend for Wuhan Hiteck Biological Pharma Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Hiteck Biological Pharma Co Other Long Term Assets Chart

Wuhan Hiteck Biological Pharma Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

98.20

189.01

214.97

186.24

357.78

Wuhan Hiteck Biological Pharma Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long Term Assets	Get a 7-Day Free Trial															207.85	366.03	364.96	357.78	363.93

Wuhan Hiteck Biological Pharma Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Wuhan Hiteck Biological Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wuhan Hiteck Biological Pharma Co Ltd (SZSE:300683) » Definitions » Other Long Term Assets

Traded in Other Exchanges

N/A

Address

Hite Science and Technology Park, Wuhan Economic and Technological Development Zone, Hubei Province, Wuhan, CHN, 430056

Website

http://www.hiteck.com.cn

Wuhan Hiteck Biological Pharma Co Ltd is a biopharmaceutical manufacturing enterprise in China. The company is primarily engaged in the development, production and sale of biological products. Its product portfolio comprises rat nerve growth factor freeze-dried powder injection, injection of anti-hepatitis B transfer factor freeze-dried powder injection, thrombin and other chemicals. The company also has more than 20 kinds of products such as hepatitis B treatment drug op Heparin and hemostatic agent thrombin.

Executives

Yan Jie	Director
Li Sheng Qiang	Executives

Wuhan Hiteck Biological Pharma Co Headlines

No Headlines